Published in Oncotarget on May 10, 2015
Thyroid hormone and anti-apoptosis in tumor cells. Oncotarget (2015) 0.80
ChIP-on-chip analysis of thyroid hormone-regulated genes and their physiological significance. Oncotarget (2016) 0.77
MiR-124 effect in neurons apoptosis in newborn rat with thyroid hypofunction. Int J Clin Exp Pathol (2015) 0.76
Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations. Biomed Res Int (2016) 0.75
Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc (2016) 0.75
Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology (2011) 3.52
Molecular aspects of thyroid hormone actions. Endocr Rev (2010) 3.29
Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology (2005) 2.34
Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol (2005) 2.05
Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol (2009) 1.82
Serum vascular endothelial growth factor (VEGF) levels correlate with number and location of micrometastases in a murine model of uveal melanoma. Br J Ophthalmol (2010) 1.53
Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression. Mol Biol Cell (2005) 1.26
Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases. Prog Retin Eye Res (2013) 1.22
In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages. J Immunol (2010) 1.15
Membrane receptor for thyroid hormone: physiologic and pharmacologic implications. Annu Rev Pharmacol Toxicol (2011) 1.12
Survival in patients with uveal melanoma in Europe. Arch Ophthalmol (2008) 1.11
Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective. Endocr Relat Cancer (2013) 1.10
Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev (2009) 1.07
Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study. Anticancer Res (2003) 1.06
A new technique for implantation of tissue culture melanoma cells in a murine model of metastatic ocular melanoma. Melanoma Res (2000) 1.06
Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology. Curr Opin Endocrinol Diabetes Obes (2010) 1.05
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives. Cancer Med (2013) 1.02
Interferon alpha 2b decreases hepatic micrometastasis in a murine model of ocular melanoma by activation of intrinsic hepatic natural killer cells. Invest Ophthalmol Vis Sci (2004) 0.99
Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma. Oncogene (2011) 0.96
A molecular revolution in uveal melanoma: implications for patient care and targeted therapy. Ophthalmology (2014) 0.91
Murine model of anterior and posterior ocular melanoma. Curr Eye Res (1995) 0.90
Adjunctive input to the nuclear thyroid hormone receptor from the cell surface receptor for the hormone. Thyroid (2013) 0.88
Propylthiouracil-induced hypothyroidism reduces xenograft tumor growth in athymic nude mice. Cancer (1999) 0.88
A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins. Br J Ophthalmol (2001) 0.86
Ocular metastasis of in vivo and in vitro derived syngeneic murine melanoma. Invest Ophthalmol Vis Sci (1987) 0.84
Small molecule hormone or hormone-like ligands of integrin αVβ3: implications for cancer cell behavior. Horm Cancer (2013) 0.84
Enucleation in consort with immunologic impairment promotes metastasis of intraocular melanomas in mice. Invest Ophthalmol Vis Sci (1984) 0.82
Management of pigmented conjunctival lesions. Ocul Surf (2012) 0.80
Thyroid hormone and anti-apoptosis in tumor cells. Oncotarget (2015) 0.80